Highlights
A collection of news and information related to Hepatitis C published by this site and its partners.
Displaying items 1-12 of 101
» View wsbtradio.com items only
1
2
3
4
5
6
7
8
9
•
Next >
-
DEALTALK-Novartis' Vasella exit opens door to Roche stake sale
Reuters* Novartis' one-third stake in Roche built up under Vasella * Vasella exit, retirement of Roche chairman could thaw relations * Roche seen as most likely buyer for the stake * Could make offer in second half of this year - analyst By Caroline...Tags: Genentech Inc., Parties and Movements, Merck & Company Incorporated, Novartis AG, Zurich (Swiss Confederation)
-
Experimental Gilead drug effective in early-stage leukemia trial
ReutersBy Deena Beasley May 15 (Reuters) - An experimental drug from Gilead Sciences Inc shrank tumors in half of leukemia patients whose cancer had returned, according to an early-stage trial that represents a new foray into oncology by the world's biggest...Tags: Pharmaceuticals, Health Treatments, Cancer, Diseases and Illnesses, HIV
-
Yale Researchers Urge More Street Work When Studying People With Both HIV, Hepatitis C
The Hartford CourantResearchers need to work harder to screen high-risk populations for people who are infected with both HIV and hepatitis C, say the authors of a new Yale University study on the incidence of co-infection in the New Haven area. The study, published Tuesday...Tags: Diseases and Illnesses, HIV, U.S. Centers for Disease Control and Prevention, Hepatitis, Health Organizations
-
HIV linked to higher chance of heart attack
ReutersNEW YORK (Reuters Health) - People with HIV are almost 50 percent more likely to have a heart attack than those who aren't infected with the virus - even after taking into account their other health risks, according to a new study. Researchers aren't...Tags: Research, Viral Diseases and Infections, University of Pittsburgh, Colleges and Universities, High Blood Pressure
-
Abbvie says Chief Scientific Officer John Leonard to retire
ReutersMay 10 (Reuters) - AbbVie Inc's chief scientific officer will be retiring in the next few months and will be involved in the process of naming a successor, the pharmaceutical company said in a regulatory filing on Friday. Chief Scientific Officer John M....Tags: Pharmaceuticals, Chemical Industry, Science, Humira (drug), Rheumatoid Arthritis
-
Muchos estadounidenses no se realizan el examen adecuado para la hepatitis C: CDC
ReutersPor Julie Steenhuysen NUEVA YORK (Reuters) - Funcionarios de salud pública de Estados Unidos informaron que sólo la mitad de la población que alguna vez estuvo infectada con el virus de la hepatitis C se realizó la prueba de detección adecuada...Tags: Viral Diseases and Infections, Disease Prevention, Diseases and Illnesses, U.S. Centers for Disease Control and Prevention
-
Many with hepatitis C don't get needed follow-up tests, CDC says
Half of all patients who have tested positive for hepatitis C have not had follow-up testing to see if they are still infected, according to the Centers for Disease Control and Prevention. That means many people are living with the disease and not...
Tags: Medical Procedures and Tests, Disease Prevention, Cirrhosis, Liver Cancer, Diseases and Illnesses
-
Many in U.S. don't get proper testing for hepatitis C- CDC
ReutersBy Julie Steenhuysen NEW YORK, May 8 (Reuters) - Only half of people in the United States who have ever been infected with hepatitis C get proper testing for the liver-destroying disease, according to U.S. health officials. Proper testing is a two-...Tags: Viral Diseases and Infections, Merck & Company Incorporated, Disease Prevention, Liver Cancer, Diseases and Illnesses
-
REUTERS SUMMIT-Biotech firms evolve from targets to acquirers
Reuters(For other news from Reuters Health Summit, click on http://www.reuters.com/summit/Health13) * Skyrocketing valuations quash talks * With financing available, many biotechs go it alone * Bankers expect steady flow of $1 bln to $5 bln pharma deals By...Tags: Pharmaceuticals, Biotechnology Industry, Biotechnology, Business Enterprises, Multiple Sclerosis
-
FDA fast tracks AbbVie hepatitis C drug
Tribune reporterAbbVie said Monday that its new hepatitis C drug regimen has been given a breakthrough therapy designation by the Food and Drug Administration, putting it on the fast track for potential approval in the United States. A breakthrough therapy...Tags: Trials, Vaccines, Diseases and Illnesses, Food and Drug Administration, Hepatitis
-
Additional question from Dr. Christopher Prince interview
Is Michigan’s law effective? The law has become more specific giving more definitions and clarifying explanations of its intent. The State has a list of approved diagnoses, which is to be expanded yearly, and conditions approved for the use of...Tags: Crime, Law and Justice, Judges, Health Treatments, Multiple Sclerosis, Justice System
-
International consortium releases hepatitis C data
Two antiviral drugs used to treat hepatitis C appear to work as well in the real world as they did during clinical trials, an international research consortium has observed. The consortium also released data that may help inform how doctors and patients...Tags: Genentech Inc., Colleges and Universities, Liver Disease, Education, Trials
May 16, 2013
|Story| Reuters
May 15, 2013
|Story| Reuters
May 14, 2013
|Story| Hartford Courant
Mar 5, 2013
|Story| Reuters
May 10, 2013
|Story| Reuters
May 9, 2013
|Story| Reuters
May 8, 2013
|Story| Los Angeles Times
May 8, 2013
|Story| Reuters
May 7, 2013
|Story| Reuters
May 6, 2013
|Story| Chicago Tribune
May 4, 2013
|Story| South Bend Tribune
May 2, 2013
|Story| South Florida Sun-Sentinel
Original site for Hepatitis C topic gallery.